In class actions, plaintiffs have less control over the proceedings
Patients can be treated not as passive recipients of a magic shot, but as active participants in their health journey with coaching, tools, and a tailored treatment plan that meets them where they are
The Shot is stronger: If your goal is maximum weight loss, the data shows that Injectable Wegovy and Zepbound still work better for the average person
Food intake declines and hunger is reduced
Global NASH Council, American Association for the Study of Liver Diseases (AASLD), EASL | The Home of Hepatology, Canadian Association for the Study of the Liver, European Liver Patients' Association - ELPA, Global Liver Institute, Priti Chawla, Obesity Matters, American Diabetes Association Fatty Liver Alliances Post GLP-1 receptor agonists (GLP-1RAs) show promise in managing metabolic dysfunction-associated steatotic liver disease (MASLD) by reducing hepatic steatosis, resolving MASH, and mitigating fibrosis progression
Canadian Medical Association journal , 107 (6), 503508